Re:FDA promised a ‘lower-cost option’ to EpiPen, but the pri...
by pas on Thursday November 29, 2018 @05:38AM
(#18559291)
Maybe they are in a metastable state, they are not forced to compete and no one is losing market share?
[ Parent
| on HN ]
There are no comments on this comment yet.